- VernacularTitle:政策提言委員会報告~漢方フレイルスコア
- Author:
Kazuyuki ISHIDA
1
;
Yoko KIMURA
2
;
Sadahiro TAMASHIMA
3
Author Information
- Keywords: The Kampo Future Vision Study Group; The Policy Advisory Committee; countermeasure against frailty; Kampo frailty score
- From:Kampo Medicine 2024;75(1):75-82
- CountryJapan
- Language:Japanese
- Abstract: “The Kampo Future Vision Study Group responsible for health and medical care of people” was established in 2016 with the aim of discussions to resolve various problems related to Kampo, and issued six proposals as important items. Among these proposals, the emphasized themes that are directly linked to clinical practice are “Kampo as a supportive treatment for cancer” and “Kampo as a countermeasure against frailty in the elderly.” The Japan Society of Oriental Medicine decided on a policy to be involved in these themes and established the Proposal-Discussing Committee (later absorbed into the Policy Advisory Committee). At first, the committee asked experts to present the research status of Kampo medicine as supportive care for cancer and as countermeasures against frailty. The committee, then, decided to lead clinical research by itself on frailty treatment with Kampo medicine. In such clinical research, evaluation criteria for judging therapeutic effects are necessary. Therefore, the existing well-defined diagnostic criteria were combined to create a Kampo frailty score. This article explains the Kampo frailty score, citing the supporting literature.